Spots Global Cancer Trial Database for small cell carcinoma
Every month we try and update this database with for small cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer | NCT01642251 | Extensive Stage... Large Cell Lung... Neuroendocrine ... Small Cell Carc... Stage IV Non-Sm... | Cisplatin Etoposide Veliparib Placebo | 18 Years - | National Cancer Institute (NCI) | |
| Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer | NCT04926181 | Small Cell Neur... Prostate Cancer Small Cell Carc... | Apalutamide Cetrelimab | 18 Years - | University of California, San Francisco | |
| Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer | NCT00907569 | Lung Neoplasm Small Cell Carc... | Hypofractionate... | 18 Years - | AHS Cancer Control Alberta | |
| Hypofractionated Radiotherapy for Small Cell Lung Cancer | NCT00469222 | Lung Neoplasm Small Cell Carc... | hypofractionate... | 18 Years - | AHS Cancer Control Alberta | |
| A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors | NCT05551117 | Castration-Resi... Androgen-Indepe... Androgen-Insens... Androgen-Resist... Hormone Refract... Anal Cancer Anal Neoplasm Carcinoma, Squa... Head and Neck S... Laryngeal Squam... Oral Squamous C... Malignant Melan... Melanoma Non-small Cell ... Non-small Cell ... Small-cell Lung... Small Cell Carc... | vobramitamab du... vobramitamab du... vobramitamab du... | 18 Years - | MacroGenics | |
| Cone Beam CT Scanning in Lung and Bladder Cancer. | NCT00469066 | Lung Neoplasm Small Cell Carc... Bladder Carcino... | 18 Years - | AHS Cancer Control Alberta | ||
| RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) | NCT02489903 | Small Cell Carc... Carcinoma, Non-... Neuroendocrine ... Ovarian Epithel... | RRx-001 Cisplatin Etoposide Carboplatin Irinotecan Vinorelbine Doxil Gemcitabine Taxane Paclitaxel Nab-Paclitaxel Pemetrexed | 18 Years - | EpicentRx, Inc. | |
| Quantifying Systemic Immunosuppression to Personalize Cancer Therapy | NCT05621837 | Melanoma Breast Cancer Renal Cell Carc... Urinary Bladder... Squamous Cell C... Small Cell Carc... NSCLC | MDSC quantifica... | 18 Years - 90 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer | NCT00466232 | Small Cell Carc... Lung Cancer | Topotecan Sorafenib | - | HealthPartners Institute | |
| A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. | NCT03910660 | Prostate Cancer Neuroendocrine ... Small Cell Carc... | BXCL701 plus Pe... BXCL701 monothe... | 18 Years - | BioXcel Therapeutics Inc | |
| A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors | NCT05551117 | Castration-Resi... Androgen-Indepe... Androgen-Insens... Androgen-Resist... Hormone Refract... Anal Cancer Anal Neoplasm Carcinoma, Squa... Head and Neck S... Laryngeal Squam... Oral Squamous C... Malignant Melan... Melanoma Non-small Cell ... Non-small Cell ... Small-cell Lung... Small Cell Carc... | vobramitamab du... vobramitamab du... vobramitamab du... | 18 Years - | MacroGenics | |
| Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer | NCT00907569 | Lung Neoplasm Small Cell Carc... | Hypofractionate... | 18 Years - | AHS Cancer Control Alberta | |
| Hypofractionated Radiotherapy for Small Cell Lung Cancer | NCT00469222 | Lung Neoplasm Small Cell Carc... | hypofractionate... | 18 Years - | AHS Cancer Control Alberta | |
| Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma | NCT02881125 | Small Cell Carc... | Nortriptyline H... Paclitaxel | 18 Years - | University of Washington | |
| Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer | NCT04926181 | Small Cell Neur... Prostate Cancer Small Cell Carc... | Apalutamide Cetrelimab | 18 Years - | University of California, San Francisco |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
